Zelira Therapeutics Ltd (ASX:ZLD) founder and chairman Osagie Imasogie and deputy chairman Harry Karelis speaks to Proactive on the recent acquisition of Ilera Therapeutics LLC.
Following overwhelming shareholder support, the merger will create a global medicinal cannabis company called Zelira Therapeutics Limited.
The merger will bring together a portfolio of revenue-generating medicines and products undergoing clinical development that are expected to enter the market from 2020.